NEW YORK (GenomeWeb News) — Coda Genomics has pocketed a $7 million Series C round of private equity financing and plans to use the cash to fund and manage growth, particularly in its collaborations with pharmaceutical companies, the company said today.
 
Coda CEO Robert Molinari said the financing will push growth in “several opportunistic areas,” including translational engineering, funding a biofuel enzyme initiative with the University of California, Irvine, and developing a therapeutic candidate demonstration project.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.